Stay updated with breaking news from Director Wayne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) had its price objective cut by Barclays from $40.00 to $18.00 in a report published on Monday, Marketbeat.com reports. They currently have an overweight rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the stock. Chardan Capital restated a buy rating and set […]
HC Wainwright reaffirmed their buy rating on shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) in a research note published on Friday, Benzinga reports. HC Wainwright currently has a $38.00 price target on the biotechnology company’s stock. Other analysts also recently issued reports about the stock. Truist Financial reaffirmed a buy rating and set a […]
Truist Financial reaffirmed their buy rating on shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) in a research note published on Friday morning, Benzinga reports. The firm currently has a $17.00 price objective on the biotechnology company’s stock. IOVA has been the subject of a number of other research reports. Stifel Nicolaus reduced their price […]
Mizuho restated their buy rating on shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) in a research note published on Friday, Benzinga reports. Mizuho currently has a $30.00 price objective on the biotechnology company’s stock. Several other brokerages have also commented on IOVA. HC Wainwright reaffirmed a buy rating and issued a $38.00 price target […]
HC Wainwright reiterated their buy rating on shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) in a research report report published on Friday morning, Benzinga reports. The firm currently has a $38.00 price objective on the biotechnology company’s stock. A number of other analysts have also issued reports on the stock. Wells Fargo & Company […]